6/13/2024  5:35:03 PM Chg. -0.120 Volume Bid6/13/2024 Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
29.930EUR -0.40% 1.01 mill.
Turnover: 30.12 mill.
-Bid Size: - -Ask Size: - 16.78 bill.EUR - -

Business description

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
 

Management board & Supervisory board

CEO
Michael Sen
Management board
Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser
Supervisory board
Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Stefanie Balling , Bernd Behlert , Michael Diekmann , Grit Genster , Konrad Kölbl , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Oscar Romero de Paco , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel
 

Company data

Name: Fresenius SE & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-608-0
Fax: -
E-mail: pr-fre@fresenius.com
Internet: www.fresenius.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 56.49%
IPO date: 12/18/1986

Investor relations

Name: Markus Georgi
IR phone: +49-6172-608-2485
IR Fax: +49-6172-608-2488
IR e-mail: ir-fre@fresenius.com

Company calendar

CW 31 | 7/31/2024 Interim Report 2nd Quarter/6 Months
CW 45 | 11/6/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
61.22%
Else Kröner-Fresenius-Stiftung
 
26.33%
Harris Associates Investment Trust
 
5.02%
BlackRock, Inc.
 
4.99%
Amundi S.A.
 
2.44%
Others
 
0.00%